ELEV
Income statement / Annual
Last year (2023), Elevation Oncology, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Elevation Oncology, Inc.'s net income was -$45.70 M.
See Elevation Oncology, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$39,000.00 |
$27,000.00 |
$18,000.00 |
$15,000.00 |
$0.00 |
| Gross Profit |
-$39,000.00 |
-$27,000.00 |
-$18,000.00 |
-$15,000.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$25.43 M
|
$78.72 M
|
$23.60 M
|
$15.48 M
|
$5.34 M
|
| General & Administrative
Expenses |
$14.90 M
|
$15.83 M
|
$8.45 M
|
$1.80 M
|
$816,000.00
|
| Selling & Marketing
Expenses |
-$39,000.00
|
$0.00
|
$0.00
|
$0.00
|
$543,184.00
|
| Selling, General &
Administrative Expenses |
$14.90 M
|
$15.83 M
|
$8.45 M
|
$1.80 M
|
$544,000.00
|
| Other Expenses |
$5.11 M |
-$506,000.00 |
$7,000.00 |
$11,000.00 |
$0.00 |
| Operating Expenses |
$45.45 M |
$94.55 M |
$32.05 M |
$17.28 M |
$5.88 M |
| Cost And Expenses |
$45.45 M |
$94.55 M |
$32.05 M |
$17.28 M |
$5.88 M |
| Interest Income |
$3.90 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$4.17 M |
$479,000.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$39,000.00
|
$27,000.00
|
$18,000.00
|
$15,000.00
|
$3.57 M
|
| EBITDA |
-$40.30 M
|
-$94.55 M
|
-$32.03 M
|
-$17.26 M
|
-$5.88 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$229,000.00
|
-$506,000.00
|
$7,000.00
|
$11,000.00
|
-$5.25 M
|
| Income Before Tax |
-$45.67 M |
-$95.06 M |
-$32.04 M |
-$17.27 M |
-$5.88 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$30,000.00 |
$25,000.00 |
-$218,558.00 |
-$191,297.00 |
-$8,823.00 |
| Net Income |
-$45.70 M |
-$95.08 M |
-$32.04 M |
-$17.27 M |
-$5.88 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
| EPS |
-1.34 |
-4.09 |
-1.38 |
-0.73 |
-0.25 |
| EPS Diluted |
-1.34 |
-4.09 |
-1.38 |
-0.73 |
-0.25 |
| Weighted Average Shares
Out |
$34.08 M
|
$23.27 M
|
$23.21 M
|
$23.76 M
|
$23.76 M
|
| Weighted Average Shares
Out Diluted |
$34.08 M
|
$23.27 M
|
$23.21 M
|
$23.76 M
|
$23.76 M
|
| Link |
|
|
|
|
|
